Evidence map›Paper›PMID 37199746›Full record

ArticleHuman genetics2023

Spinocerebellar ataxia 38: structure-function analysis shows ELOVL5 G230V is proteotoxic, conformationally altered and a mutational hotspot.

Enza Ferrero, Eleonora Di Gregorio, Marta Ferrero, Erika Ortolan, Young-Ah Moon, Antonella Di Campli, Lisa Pavinato, Cecilia Mancini, Debasmita Tripathy, Marta Manes and 11 more

Open access · hybridAbstract read
In one paragraph

Article in Human genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Impact of Elovl5 Deficiency on Cerebellar Excitatory Synaptic Transmission in Mice.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  2. Article
  3. Spinocerebellar Ataxia Type 34:Journal of clinical neurology (Seoul, Korea) · 2025
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 12 institutions in 4 countries.

Enza Ferrero *Department of Medical Sciences, University of Torino, Via Santena 19, 10126, Turin, Italy.
Eleonora Di Gregorio *Unit of Medical Genetics, Città della Salute e Della Scienza Hospital, Turin, Italy.
Marta FerreroExperimental Zooprophylactic Institute of Piedmont, Liguria and Aosta Valley, Turin, Italy.
Erika OrtolanDepartment of Medical Sciences, University of Torino, Via Santena 19, 10126, Turin, Italy.
Young-Ah MoonDepartment of Molecular Medicine, Inha University College of Medicine, Incheon, South Korea.
Antonella Di CampliInstitute of Protein Biochemistry, Italian National Research Council, Naples, Italy.
Lisa PavinatoDepartment of Medical Sciences, University of Torino, Via Santena 19, 10126, Turin, Italy.
Cecilia ManciniDepartment of Medical Sciences, University of Torino, Via Santena 19, 10126, Turin, Italy.
Debasmita TripathyDepartment of Cellular, Computational and Integrative Biology, University of Trento, Trento, Italy.
Marta ManesDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Eriola HoxhaNeuroscience Institute Cavalieri Ottolenghi, Orbassano and Department of Neuroscience, University of Torino, Turin, Italy.
Chiara CostanziDepartment of Neurology, Cremona Hospital, Cremona, Italy.
Elisa PozziDepartment of Medical Sciences, University of Torino, Via Santena 19, 10126, Turin, Italy.
Matteo Rossi SebastianoDepartment of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy.
Nico MitroDepartment of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.
Filippo TempiaNeuroscience Institute Cavalieri Ottolenghi, Orbassano and Department of Neuroscience, University of Torino, Turin, Italy.
Donatella CarusoDepartment of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.
Barbara BorroniDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Manuela BassoDepartment of Cellular, Computational and Integrative Biology, University of Trento, Trento, Italy.
Michele SalleseCentre for Advanced Studies and Technology, G. d'Annunzio University of Chieti-Pescara, Chieti, Italy.
Alfredo BruscoDepartment of Medical Sciences, University of Torino, Via Santena 19, 10126, Turin, Italy. alfredo.brusco@unito.it.ORCID http://orcid.org/0000-0002-8318-7231
University of Turin · ITNeuroscience Institute · ITUniversity of Brescia · ITUniversity of Chieti-Pescara · ITUniversity of Milan · ITUniversity of Trento · ITAzienda Ospedaliera Citta' della Salute e della Scienza di Torino · ITBambino Gesù Children's Hospital · ITCTO Hospital · ITInha University · KRIstituti Ospitalieri di Cremona · ITIstituto Zooprofilattico Sperimentale del Piemonte Liguria e Valle d'Aosta · IT

Funding

Dipartimento di Scienze Mediche, Università degli Studi di Torino RiLoFondazione Telethon GGP12220Fondazione Telethon GGP14225Ministero dell'Università e della Ricerca 20203P8C3XMinistry of Education, Science and Technology 2021R1A2C1012480
6 · The paper itself

Abstract

Fatty acid elongase ELOVL5 is part of a protein family of multipass transmembrane proteins that reside in the endoplasmic reticulum where they regulate long-chain fatty acid elongation. A missense variant (c.689G>T p.Gly230Val) in ELOVL5 causes Spinocerebellar Ataxia subtype 38 (SCA38), a neurodegenerative disorder characterized by autosomal dominant inheritance, cerebellar Purkinje cell demise and adult-onset ataxia. Having previously showed aberrant accumulation of p.G230V in the Golgi complex, here we further investigated the pathogenic mechanisms triggered by p.G230V, integrating functional studies with bioinformatic analyses of protein sequence and structure. Biochemical analysis showed that p.G230V enzymatic activity was normal. In contrast, SCA38-derived fibroblasts showed reduced expression of ELOVL5, Golgi complex enlargement and increased proteasomal degradation with respect to controls. By heterologous overexpression, p.G230V was significantly more active than wild-type ELOVL5 in triggering the unfolded protein response and in decreasing viability in mouse cortical neurons. By homology modelling, we generated native and p.G230V protein structures whose superposition revealed a shift in Loop 6 in p.G230V that altered a highly conserved intramolecular disulphide bond. The conformation of this bond, connecting Loop 2 and Loop 6, appears to be elongase-specific. Alteration of this intramolecular interaction was also observed when comparing wild-type ELOVL4 and the p.W246G variant which causes SCA34. We demonstrate by sequence and structure analyses that ELOVL5 p.G230V and ELOVL4 p.W246G are position-equivalent missense variants. We conclude that SCA38 is a conformational disease and propose combined loss of function by mislocalization and gain of toxic function by ER/Golgi stress as early events in SCA38 pathogenesis.

Indexed as

Spinocerebellar AtaxiasAmino Acid SequenceAnimalsAtaxiaFatty Acid ElongasesMiceMutationFatty Acid Elongases

Identifiers

PMID37199746
PMCPMC10449689
OpenAlexW4377010964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.